November 2019

New Analysis Finds Large Drugmakers Could Lose $1 Trillion in Sales and Still Be the Most Profitable Industry

2019-11-15T12:34:05-05:00November 15th, 2019|Drug Cost News, News|

A new analysis of publicly reported financial data by researchers at West Health Policy Center and Johns Hopkins Bloomberg School of Public Health finds that large, brand-name drug manufacturers would still be the most profitable industry sector even with $1 trillion in lower sales, all while maintaining current research investments. Read about the report's findings >

October 2019

September 2019